LYFCX Holdings Information

LYFCX is a mutual fund with a total of 63 individual holdings. The top holdings are First American Treasury Obligations Fund Class X stock at 7.72%, Gilead Sciences at 7.18%, AstraZeneca at 5.63%, Vertex Pharmaceuticals at 5.60%, and Ionis Pharmaceuticals at 3.74%.

Total Holdings

Top 10 Percentage

46.76%

Asset Class

Equity

Fund Category

Health

Assets

41.26M

Forward PE Ratio

16.83

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	FXFXX	First American Treasury Obligations Fund Class X	7.72%	3,035,293
2	GILD	Gilead Sciences, Inc.	7.18%	20,260
3	LON: AZN	AstraZeneca PLC	5.63%	11,232
4	VRTX	Vertex Pharmaceuticals Incorporated	5.60%	4,931
5	IONS	Ionis Pharmaceuticals, Inc.	3.74%	19,587
6	INSM	Insmed Incorporated	3.57%	8,583
7	INCY	Incyte Corporation	3.41%	14,245
8	ROIV	Roivant Sciences Ltd.	3.36%	47,667
9	ARGX	argenx SE	3.33%	1,794
10	NBIX	Neurocrine Biosciences, Inc.	3.22%	9,607
11	AXSM	Axsome Therapeutics, Inc.	2.77%	6,438
12	ASND	Ascendis Pharma A/S	2.63%	4,526
13	APGE	Apogee Therapeutics, Inc.	2.43%	11,369
14	PTGX	Protagonist Therapeutics, Inc.	2.42%	9,040
15	AMGN	Amgen Inc.	2.08%	2,329
16	RYTM	Rhythm Pharmaceuticals, Inc.	2.06%	9,297
17	ABBV	AbbVie Inc.	1.96%	3,544
18	BIIB	Biogen Inc.	1.79%	3,835
19	SNY	Sanofi	1.76%	14,382
20	JAZZ	Jazz Pharmaceuticals plc	1.71%	3,561
21	CPRX	Catalyst Pharmaceuticals, Inc.	1.47%	23,286
22	ORKA	Oruka Therapeutics, Inc.	1.44%	11,506
23	BNTX	BioNTech SE	1.27%	5,616
24	KRYS	Krystal Biotech, Inc.	1.26%	1,918
25	EWTX	Edgewise Therapeutics, Inc.	1.25%	15,615

Showing 25 of 63 holdings

Subscribe to see the full list

Activate Now

As of Mar 31, 2026